Entries by andrew

Human-Centered Learning

By Nathan Pienkowski Imagine you’re planning to design a new product that will help its users solve a specific problem. Before beginning the design process, doesn’t it make sense to first analyze the problem, understand how it affects people (your potential customers), and then design the product with end users’ perspectives and needs in mind?  […]

,

When Business Objectives Trump Learning Objectives

By Nathan Pienkowski Should a Learning and Development (L&D) organization deliver above and beyond the call of duty, going “all in” to apply the latest in instructional design to every single project?  That’s an interesting question and, like most interesting questions, it defies a simple yes or no answer. Sometimes, the answer is yes.  However, […]

,

How to Do Less with Less

By Sue Iannone Let’s start this article by establishing one fact up front:  That old cliché about how we all should “do more with less” is bogus.  Perhaps not it all cases, but it’s definitely bogus when it comes to leading a Learning and Development (L&D) organization in a biopharma company. Training organization leaders often […]

Training for Global Product Launch: Five Tips

By Garry O’Grady Launching a new product is a complex undertaking involving a range of stakeholders, all of whom must work together in a coordinated manner.  If you really want to dial the complexity “up to eleven,” try launching a new product globally.  Over the years, we’ve had the privilege of working with clients before, […]

Are You a Strategic Leader…Or Overwhelmed?

By Sue Iannone Part Two in a Series In Part One, we outlined seven characteristics of the “Future Learning and Development Organization.”  Those characteristics are shared by teams that evolve beyond firefighting mode, look forward in a strategic way, and focus on achieving the company’s business objectives rather than struggling to keep up with daily […]

,

Getting Out of Today and Into the Future

By Sue Iannone and Garry O’Grady Part One in a Series The biopharmaceutical industry is not known for dull stability.  Think about it… Companies must remain on a “treadmill” of innovation, always working to replace products as they go off patent.  Regulatory and legislative changes are always being discussed, passed, or implemented.  Market dynamics are […]